A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Essen Biotech
Washington University School of Medicine
Dana-Farber Cancer Institute
Imugene Limited
Dana-Farber Cancer Institute
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Dana-Farber Cancer Institute
Curacell Holding AB
Hadassah Medical Organization
The First Affiliated Hospital with Nanjing Medical University
TCRCure Biopharma Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Medicenna Therapeutics, Inc.
Indapta Therapeutics, INC.
Vall d'Hebron Institute of Oncology
Guangzhou FineImmune Biotechnology Co., LTD.
Essen Biotech
Essen Biotech
Vall d'Hebron Institute of Oncology
Essen Biotech
Essen Biotech
Essen Biotech
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Guangzhou FineImmune Biotechnology Co., LTD.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Tongji Hospital
Henan Cancer Hospital
Erasmus Medical Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sheba Medical Center
St. Anna Kinderkrebsforschung